Skip to main content
. 2020 Jul 31;21(15):5469. doi: 10.3390/ijms21155469

Figure 4.

Figure 4

Figure 4

Hepatic inflammatory proteins and HO protein levels in lean, HFD-, and HFD+ PSO-treated mice. (A) Representative western blots for NOV/CCN3, interleukin-6 (IL-6), and β-actin. (B) Quantitation of the hepatic levels of NOV/CCN3 protein levels. (C) Quantitation of the hepatic levels of IL-6. (D) Representative western blots for p-P65, total P65, and β-actin. (E) Quantitation of the hepatic p-P65 to total P65 ratio. (F) Representative western blots for heme oxygenase-1 (HO-1), heme oxygenase-2 (HO-2), and β-actin. (G) Quantitation of the hepatic levels of HO-1. (H) Quantitation of the hepatic levels of HO-2. * = different p < 0.05 from corresponding value in lean mice. # = different p < 0.05 from corresponding value in HFD mice. n = 6/group.